Dr. Niemann on Notable Findings from the GLOW Trial in CLL
January 6th 2023Carsten Niemann, MD, PhD, discusses notable data on patient survival outcomes, as well as the impact of minimal residual disease in the peripheral blood from the phase 3 GLOW trial in patients with chronic lymphocytic leukemia.
Read More